Insider buying last 90 days
No open-market insider purchases were filed for CI in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every CI insider filing, plotted on the chart in Gekko.Open CI in Gekko
NYSE: CI
Cigna (CI) Stock Analysis & Forecast
$275.28−0.72 (−0.3%)
Close on Sep 18, 2026. Page updated Sep 19, 9:17 pm ET.
Gekko Brief
AI summaryCigna shares close at $275.28, down 0.3%, sitting between the 50-day average of $282.94 and the 200-day average of $279.85. The stock is down 0.8% over one month and 7.2% over the past year, though up 4% over six months. The GekkoIndex reads 62.9, placing CI in the Accumulation zone, and the price stands 37.8% below Gekko Fair Value of $442.38.
Coverage this week centers on Cigna's push into artificial intelligence, with CI expanding AI tools across care coordination and specialty pharmacy as it works to manage elevated healthcare costs and improve access. Separate coverage highlights a Cigna Group report on volunteering and wellbeing, and another piece frames CI as a long-term growth stock candidate. A filing shows RFG Advisory LLC raised its CI stake in the second quarter.
Cigna's next earnings report is set for 29 October 2026, before the open, 39 days out and beyond a typical 20-trading-day holding window. The last report, on 30 July 2026, showed adjusted EPS of $7.78 against an estimate of $7.58, though shares reacted -5.9%; CI has beaten estimates in 7 of the last 8 quarters, with an average absolute reaction of 6.5%. Analyst consensus stands at 13 buy and 5 hold ratings among 18 firms, with a consensus target of $339.36. Seasonally, the next 20 trading days have averaged a 2.9% gain over 5 years, rising in 5 of them, a pattern worth noting alongside the 39-day gap to the next earnings date.
Written by AI and checked automatically against the figures on this page. Generated Sep 20, 2026 from the data above.
Price vs fair value
Close $275.28200-day averageGekko Fair Value $442.38
Key stats
- Market cap
- $72.74B
- P/E ratio
- 11.6
- Forward P/E
- 8.4
- EPS, TTM
- $23.79
- Revenue, TTM
- $282.4B
- Profit margin
- 2.3%
- Dividend yield
- 2.19%
- Beta
- 0.32
- Volume
- 2.33M avg 1.40M
- 1-year return
- −7.2%
- Typical daily move
- ±2.4%
- Typical 20-day move
- ±4.1%
- 50-day average
- $282.94
- 200-day average
- $279.85
- Next earnings
- Oct 29 before open
- Shares outstanding
- 264.2M
Cigna swing-trade checklist
Cigna scores 4 supportive, 1 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive1 mixed0 headwinds
- Trendmixed
Averages disagree
Close $275.28 sits between the 50-day ($282.94) and 200-day ($279.85) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
62.9, Accumulation
Reading 62.9 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
37.8% below
Price is 37.8% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 39 days
Next report Oct 29, 2026, 39 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+2.9% on average
From this point in the calendar, the next 20 trading days averaged +2.9% over 5 years, rising in 5 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Cigna stock chart and price history
Cigna closed at $275.28 on Sep 18, 2026, −7.2% over the past year, inside a 52-week range of $239.51 to $315.47.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −0.8%
- 3 months
- −1.4%
- 6 months
- +4.0%
- 1 year
- −7.2%
The full CI chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open CI in Gekko
Follow Cigna through every session
Put CI on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track CI in GekkoFree for 7 days. No credit card required.
About Cigna
Cigna sells health insurance and related services to individuals, employers, unions, and government programs across the United States, with additional health coverage offered internationally to multinational employers and their mobile workforces. It is known for a broad mix of medical, pharmacy, dental, vision, and behavioral health products, along with Medicare plans for seniors and coverage sold both on and off public exchanges.
The business runs through two main arms. Evernorth handles pharmacy services, benefits administration, care management, and data-driven health solutions for health plans, employers, government bodies, and providers. Cigna Healthcare covers insurance products for insured and self-insured clients, seniors, and individual buyers, and also issues permanent life insurance policies that companies use to fund future employee benefit obligations. Products reach customers through brokers, consultants, direct sales to employers and unions, and both private and public insurance exchanges.
Cigna traces its founding to 1792 and is headquartered in Bloomfield, Connecticut. Its shares are listed on the NYSE under the ticker CI.
- Listed
- NYSE
- Sector
- Health services
- Industry
- Managed health care
- Website
- thecignagroup.com
Cigna GekkoIndex: the smart money zone
Cigna’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 62.9, in the Accumulation zone, up 2.9 points over five sessions.
62.9Accumulation
Up 2.9 points over five sessions.
Reading for Sep 18, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 41 | +2.5% | +6.4% | ||
| Accumulation (current zone) | 215 | +0.9% | +1.3% | ||
| Neutral | 380 | −0.7% | −1.8% | ||
| Distribution | 23 | −0.4% | +1.3% | ||
| Selling | 3 | Too few readings yet | |||
Average CI share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the CI price, zone by zone.Track CI in Gekko
Is Cigna stock overvalued? Gekko Fair Value
Cigna trades 37.8% below Gekko Fair Value of $442.38, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Cigna shares are worth, recalculated every trading day.
$442.38
Gekko Fair Value, Sep 19, 2026
37.8% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open CI in Gekko
Cigna insider and Congress trading
No open-market insider purchases were filed for Cigna, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in CI were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for CI, plotted on the chart in Gekko.Open CI in Gekko
Buybacks
Cigna has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $280.0M
- As a share of market cap
- 0.38%
From company filings.
Hedge funds and billionaires quarter ended Jun 30
3of the funds Gekko tracks hold CI.
1added0opened2trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko
Cigna earnings: next date and track record
Cigna reports on Oct 29, 2026, before the open (39 days away), and beat the EPS estimate in 7 of its last 8 reports.
Next earnings report
Oct 29, 2026
Expected before the open, 39 days away
- EPS estimate
- $7.51
- Revenue estimate
- $72.65B
7 of 8reports beat the EPS estimate
±6.5%average move across the report
2 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 30, 2026 AI summary
- What they said
- Cigna Group reported Q2 2026 total revenues of $71.7 billion and adjusted EPS of $7.78, exceeding expectations for both Evernorth and Cigna Healthcare segments. Evernorth revenues grew 6% year-over-year, while Specialty and Care Services delivered 22% pretax adjusted earnings growth driven by Accredo and specialty pharmacy services. Faster-than-expected biosimilar and specialty generic adoption contributed to affordability improvements. After-tax special item charges totaled $153 million or $0.58 per share.
- Guidance
- Management reiterated full year 2026 financial outlook, incorporating anticipated share repurchases and dividends. Leadership expressed confidence in sustained momentum across Evernorth and Cigna Healthcare, citing strong execution and strategic positioning in specialty pharmacy and AI-driven care innovation.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 30, 2026 | $7.78 est $7.58 | $71.67B est $70.14B | −5.9% |
| Apr 30, 2026 | $7.79 est $7.61 | $68.49B est $66.29B | −3.2% |
| Feb 5, 2026 | $8.08 est $7.88 | $72.47B est $70.31B | +7.5% |
| Oct 30, 2025 | $7.83 est $7.64 | $69.75B est $67.58B | −18.3% |
| Jul 31, 2025 | $7.20 est $7.16 | $67.23B est $62.91B | −12.0% |
| May 2, 2025 | $6.74 est $6.35 | $65.50B est $60.20B | −0.6% |
| Jan 30, 2025 | $6.64 est $7.82 | $65.72B est $63.44B | −3.0% |
| Oct 31, 2024 | $7.51 est $7.25 | $62.77B est $59.47B | +1.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Cigna stock forecast and analyst price targets
Analysts’ average 12-month price target for Cigna is $339.36, +23.3% from the last close, from 18 firms rating the stock in the last 90 days.
$339.36consensus 12-month target, +23.3% from the last close
Now $275.28Avg $339.36
Low $290High $381
Each firm’s latest rating in the last 90 days: 18 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 16 | TD Cowen | $338 | +22.8% |
| Sep 15 | Wells Fargo | $307 | +11.5% |
| Sep 9 | Bernstein | $381 | +38.4% |
| Sep 9 | Evercore ISI | $290 | +5.3% |
| Sep 4 | Bernstein | $381 | +38.4% |
+1.3%average 20-day move after past Accumulation readings
+2.9%average move over the next 20 trading days in the last 5 years
±2.4%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Cigna seasonality: the next 20 trading days
Over the next 20 trading days from Sep 19, Cigna averaged +2.9% across the last 5 years, rising in 5 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −0.8% | 2 of 5 |
| Next 10 trading days | +0.1% | 1 of 5 |
| Next 15 trading days | +0.6% | 3 of 5 |
| Next 20 trading days | +2.9% | 5 of 5 |
| Next 30 trading days | −0.2% | 3 of 5 |
For scale, CI’s typical 20-trading-day move in either direction is about 4.1%.
Cigna market cap and key statistics
Cigna’s market cap is $72.74B, with a P/E ratio of 11.6 and revenue of $282.4B over the last twelve months.
Valuation
- Market cap
- $72.74B
- P/E ratio
- 11.6
- Forward P/E
- 8.4
- EPS, TTM
- $23.79
- Gekko Fair Value
- $442.38
Trading
- Volume
- 2.33M
- Avg volume, 20 days
- 1.40M
- 52-week high
- $315.47
- 52-week low
- $239.51
- Shares outstanding
- 264.2M
Financials
- Revenue, TTM
- $282.4B
- Profit margin
- 2.3%
- Return on equity
- 16.8%
- Quarterly earnings growth, YoY
- +10.2%
Risk and income
- Beta
- 0.32
- Typical daily move
- ±2.4%
- Typical 20-day move
- ±4.1%
- Dividend yield
- 2.19%
Cigna stock news this week
4 headlines about Cigna from the past week, newest first, each linking to the publisher.
- Can Cigna's AI Push Help Rein In Rising Healthcare Costs?Zacks Investment Research, Sep 18
- Is Volunteering Good for Your Health? New Research From The Cigna Group Finds a Strong ConnectionPRNewsWire, Sep 16
- Why Cigna (CI) is a Top Growth Stock for the Long-TermZacks Investment Research, Sep 15
- RFG Advisory LLC Has $1.14 Million Holdings in Cigna Group $CIDefense World, Sep 13
Cigna peers
Cigna’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| UNHUnitedHealth | Accumulation | 0.2% below |
| ELVElevance Health | Neutral | 33.5% below |
| HUMHumana | Accumulation | 24.5% below |
| CNCCentene | Neutral | 23.2% below |
| MOHMolina Healthcare | Neutral | 40.3% below |
| OSCROscar Health | Neutral | 0.5% below |
A peer links to its own page where one exists.
Cigna stock FAQ
What is Cigna’s market cap?
Cigna’s market cap is $72.74B at the Sep 18, 2026 close of $275.28, with 264.2M shares outstanding. The shares trade on a P/E ratio of 11.6.
What is the Cigna stock forecast?
The consensus analyst 12-month price target for Cigna is $339.36, +23.3% from the last close. Of the 18 firms that rated the stock in the last 90 days, 13 rate it a buy, 5 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Cigna stock overvalued or undervalued?
On Gekko’s estimate Cigna is undervalued: the Sep 18, 2026 close of $275.28 is 37.8% below Gekko Fair Value of $442.38. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Cigna report earnings next?
Cigna is expected to report on Oct 29, 2026, before the market opens (39 days away). Analysts expect earnings of $7.51 per share on revenue of $72.65B. Cigna beat the earnings estimate in 7 of its last 8 reports, moving 6.5% on average across the report.
What is Cigna’s 52-week high and low?
Cigna’s 52-week high is $315.47 and its 52-week low is $239.51; it closed at $275.28 on Sep 18, 2026, −7.2% over the past year.
Is Cigna stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (gekkoindex, fair value, earnings risk and seasonality), 1 as mixed (trend). The checklist is a description of current data, not a recommendation.
How this page works
Prices and signals update after every US market close; the GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Cigna the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,349 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.